Since M3H67 reactivity was associated with tumor progression while NY-BR-1 represents a differentiation antigen it might be possible that these tumors with a high M3H67 reactivity and simultaneous absence of NY-BR-1 expression behave in a tumorbiological aggressive fashion. This evidence concerns the gene ANKRD30A and neoplasm.